1. Home
  2. COGT vs WOOF Comparison

COGT vs WOOF Comparison

Compare COGT & WOOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COGT
  • WOOF
  • Stock Information
  • Founded
  • COGT 2014
  • WOOF 1965
  • Country
  • COGT United States
  • WOOF United States
  • Employees
  • COGT N/A
  • WOOF N/A
  • Industry
  • COGT Biotechnology: Pharmaceutical Preparations
  • WOOF Other Specialty Stores
  • Sector
  • COGT Health Care
  • WOOF Consumer Discretionary
  • Exchange
  • COGT Nasdaq
  • WOOF Nasdaq
  • Market Cap
  • COGT 1.1B
  • WOOF 937.4M
  • IPO Year
  • COGT 2018
  • WOOF 2021
  • Fundamental
  • Price
  • COGT $13.05
  • WOOF $3.67
  • Analyst Decision
  • COGT Strong Buy
  • WOOF Hold
  • Analyst Count
  • COGT 11
  • WOOF 11
  • Target Price
  • COGT $21.20
  • WOOF $3.91
  • AVG Volume (30 Days)
  • COGT 1.2M
  • WOOF 4.6M
  • Earning Date
  • COGT 08-05-2025
  • WOOF 08-28-2025
  • Dividend Yield
  • COGT N/A
  • WOOF N/A
  • EPS Growth
  • COGT N/A
  • WOOF N/A
  • EPS
  • COGT N/A
  • WOOF N/A
  • Revenue
  • COGT N/A
  • WOOF $6,045,495,000.00
  • Revenue This Year
  • COGT N/A
  • WOOF $0.03
  • Revenue Next Year
  • COGT N/A
  • WOOF $1.36
  • P/E Ratio
  • COGT N/A
  • WOOF N/A
  • Revenue Growth
  • COGT N/A
  • WOOF N/A
  • 52 Week Low
  • COGT $3.72
  • WOOF $2.28
  • 52 Week High
  • COGT $13.50
  • WOOF $6.29
  • Technical
  • Relative Strength Index (RSI)
  • COGT 66.38
  • WOOF 56.29
  • Support Level
  • COGT $11.87
  • WOOF $3.27
  • Resistance Level
  • COGT $13.50
  • WOOF $4.19
  • Average True Range (ATR)
  • COGT 0.55
  • WOOF 0.23
  • MACD
  • COGT 0.05
  • WOOF 0.02
  • Stochastic Oscillator
  • COGT 77.16
  • WOOF 51.85

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

About WOOF Petco Health and Wellness Company Inc.

Petco Health and Wellness Co Inc is a pet specialty retailer focused on improving the lives of pets, pet parents, and its own partners with pet care centers in approximately 50 states, the District of Columbia and Puerto Rico. The Company also offers an expanded range of consumables, supplies, and services through its website and mobile app.

Share on Social Networks: